Akifumi Yamamoto - Concepedia

Author

Akifumi Yamamoto

Also Known As

A Yamamoto, A. YAMAMOTO, A. Yamamoto, AKIFUMI YAMAMOTO, Akemi Ishida‐Yamamoto, Akifumi YAMAMOTO, Akifumi Yamamoto, Manabu Fujimoto, Sayuri Sato, Y. Fujisawa

155

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Saitama Medical University Tokyo National Hospital University of Tsukuba National Cancer Center Shinshu University

About

Akifumi Yamamoto is an author at Saitama Medical University specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	905
2	Natural Sciences	5	5	259
3	Biochemistry	5	5	259
4	Engineering	2	2	43
5	Biology	1	1	148

Akifumi Yamamoto

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective study Yasuhiro Nakamura, Ryota Tanaka, Yuri Asami, The Journal of Dermatology	2016	220
Comprehensive Analysis of Mitochondria in Roots and Hypocotyls of Soybean under Flooding Stress using Proteomics and Metabolomics Techniques Setsuko Komatsu, Akifumi Yamamoto, Takuji Nakamura, Journal of Proteome Research BotanyPlant BiochemistryRedox BiologyOxidative StressPlant Stress	2011	148
Updated statistical data for malignant melanoma in Japan Kazuyuki Ishihara, Toshiaki Saida, Akifumi Yamamoto International Journal of Clinical Oncology MedicineMelanomaCancer RegistrationMalignant MelanomaDermatology	2001	130
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial Chie Oshita, Masako Takikawa, Akiko Kume, Oncology Reports ImmunologyDendritic Cell-based VaccinationImmunodominanceImmunoeditingImmunotherapeutics	2012	102
Malignant Eccrine Spiradenoma: A Case Report and Review of the Literature Masashi Ishikawa, Yukihiro Nakanishi, Naoya Yamazaki, Dermatologic Surgery	2001	72
Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2 Hitomi Nagayama, Katsuaki Sato, Mariko Morishita, Melanoma Research ImmunologyImmunotherapyLow Dose Interleukin-2Pilot StudyTumor Immunology	2003	71
Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Ayako Suzuki, Akira Iizuka, Masaru Komiyama, PubMed	2010	71
Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary Hideki Takeuchi, Toshiaki Saeki, Keisuke Aiba, International Journal of Clinical Oncology	2015	70
Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years’ experience Kazumasa Wakamatsu, Toshiro Kageshita, Masutaka Furue, Melanoma Research MedicineAmelanotic MelanomaMelanomaPathologyMelanoma Progression	2002	69
Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey Yu Hashimoto, Hidenori Ogata, Ryo Yamasaki, Frontiers in Neurology	2018	65

Page 1